These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4731993)

  • 1. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report].
    Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E
    Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of rifampicin applied every other day for severe cavitary pulmonary tuberculosis].
    Hashimoto T; Takahashi S; Kasai K; Tamura M; Yamada M
    Kekkaku; 1972 Aug; 47(8):273-7. PubMed ID: 4660855
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial of rifampicin in the treatment of pulmonary tuberculosis. A preliminary report.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1971 May; 54(5):304-11. PubMed ID: 5580059
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
    Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term results of treatment with rifampicin in early pulmonary tuberculosis].
    Iodice F
    Arch Monaldi; 1972; 27(1):51-6. PubMed ID: 4568896
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
    Böszörmenyi M
    Gruzlica; 1974 May; 42(5):407-10. PubMed ID: 4464228
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5146090
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience with endobronchial and local use of rifampicin in tuberculosis].
    Abdurashitova MV; Stoianovskiĭ EA; Fok AIa
    Probl Tuberk; 1976 Jan; (l):35-8. PubMed ID: 995905
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of rifampicin and ethambutol in chronic pulmonary tuberculosis].
    Anastasatu K; Sibila S; Kaufman S; Bercha O; Vais F
    Probl Tuberk; 1972; 50(5):28-30. PubMed ID: 5029675
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):251-6. PubMed ID: 5460317
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of oral and intravenous rifampicin administration in the treatment of open pulmonary tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; von Sassen W; Labedzki L; Schwabe HK; Hengstmann J; Eichelbaum M
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():482-4. PubMed ID: 6647280
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5162993
    [No Abstract]   [Full Text] [Related]  

  • 19. [A five year follow-up study of antituberculosis chemotherapy with and without rifampicin (author's transl)].
    Matsumiya T; Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R; Ishii A
    Kekkaku; 1980 Feb; 55(2):43-51. PubMed ID: 7373965
    [No Abstract]   [Full Text] [Related]  

  • 20. [A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
    Yamamoto K; Aizawa H; Sasaoka M; Kawamori Y; Kakuno J
    Kekkaku; 1972 Dec; 47(12):467-73. PubMed ID: 4652425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.